Harrow to Release Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025: After Hours Announcement

Harrow Inc. Announces Fourth Quarter Financial Results Release and Conference Call Nashville, TN — In a recent business wire announcement, Harrow Inc. (Nasdaq: HROW), a prominent North American eyecare pharmaceutical company, declared that it will unveil its fourth quarter financial results and audited data for the fiscal year ending December 31, 2024, on Thursday, March…

Read More

Join Daxor Corporation at the Medaxiom Cardiovascular Transforum Conference Spring23 to Discover the Revolutionary BVA-100 Blood Volume Diagnostic and Elevate Awareness

Expert Users to Present “Blood Volume Analysis – Breaking the Heart Failure Cycle” at MedAxiom CV Transforum Spring’23 Conference Oak Ridge, TN, April 17, 2023 (GLOBE NEWSWIRE) Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will be exhibiting at the MedAxiom CV Transforum Spring’23 Conference being held at…

Read More

Former Louisiana AG Investigates Enfusion Inc.’s Proposed Sale: Is the Price Fair? – Kahn Swick Foti LLC Alerts Investors

Investigation into Enfusion, Inc.’s Proposed Sale to Clearwater Analytics New Orleans, Louisiana – Formed in the heart of the Crescent City, the law firm of Kahn Swick & Foti, LLC (“KSF”) and its former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., have taken it upon themselves to delve deeper into the proposed sale…

Read More

Clever, Personable, and Unconventional: Solana’s Record $173 Million Q3 Funding Sets Stage for 2025 Growth

Solana (SOL): A Promising Investment Opportunity in 2025 Introduction Solana (SOL) has been making waves in the cryptocurrency market recently, with Messari’s latest analysis pointing towards a bright future for the project. According to the report, Solana is set for explosive expansion in 2025, fueled by major funding, technological advancements, and growing institutional interest. Funding…

Read More

Rosen Investor Counsel: Encouraging Elastic NV Investors with a Charming Nudge from Rosen Investor Counsel

Attention Investors: Important Information Regarding Elastic N.V. (ESTC) Securities Purchased During the Class Period New York, NY – Rosen Law Firm PA, a renowned global investor rights law firm, alerts investors of Elastic N.V. (ESTC) concerning potential securities claims. The firm encourages all purchasers of Elastic securities during the period from May 31, 2024, to…

Read More

Nansen’s Cryptic Buying Spree: Ethereum Whales Quietly Stockpile as Prices Hang in the Balance

ETH Whales’ Accumulation Amid Retail Decline: A Deep Dive The cryptocurrency market has been witnessing significant shifts in late 2024 and into 2025. One intriguing trend emerging from the data is the continued accumulation of Ethereum (ETH) by large holders, despite a decline in retail balances. In this article, we’ll delve deeper into this phenomenon,…

Read More

“Breaking News: AbbVie Shatters Expectations with Impressive Q4 Earnings and Sales, Boosts Outlook for Top-Selling Drugs!”

ABBV’s Fourth-Quarter Earnings Beat Estimates Immunology Drugs Forecast Raised to Over $31 Billion What Does This Mean for Investors? ABBV, a pharmaceutical company, recently reported fourth-quarter earnings and sales that surpassed analysts’ estimates. This news has caused a surge in the company’s stock price, leading to excitement among investors. However, the most significant news from…

Read More